So, when overexpressed, TFAM reduced all of these HF effects by inhibiting the NFAT4-MMP9 cardiac remodeling cascade, postulating TFAM as a possible therapeutic approach to cardiac pathologies [38–39]. This evidence concerns the gene TFAM and hydrops fetalis.